There is no single age when everyone should start BHRT. The right time depends on symptoms, life stage, hormone patterns, medical history, safety risks, and personal goals. For many women, BHRT is considered during perimenopause or menopause when symptoms such as hot flashes, night sweats, sleep disruption, mood changes, brain fog, vaginal dryness, painful sex, low libido, urinary symptoms, or quality-of-life changes become significant. Some people need hormone therapy earlier because of premature menopause, surgical menopause, chemotherapy, or ovarian insufficiency. Men may consider testosterone therapy when symptoms of testosterone deficiency are present and low testosterone is confirmed on proper testing. Age matters, but symptoms, timing, risk, and clinical context matter more.

Key Points

• There is no universal starting age. BHRT should not be started just because someone reaches a certain birthday. It should be considered when symptoms, life stage, labs when appropriate, and safety profile support treatment.
• Women often consider BHRT in perimenopause or menopause. Perimenopause can begin years before periods stop and may bring hot flashes, night sweats, insomnia, anxiety, mood swings, cycle changes, brain fog, vaginal dryness, or low libido.
• Earlier treatment may be appropriate for early menopause. Women with premature ovarian insufficiency, surgical menopause, chemotherapy-induced menopause, or menopause before the usual age range may need a different risk-benefit discussion.
• Men should not start TRT based on age alone. Testosterone therapy is usually considered when symptoms of testosterone deficiency are present and morning testosterone levels are consistently low on appropriate testing.
• Timing can affect risk and benefit. For women, starting menopause hormone therapy closer to menopause may have a different risk-benefit profile than starting many years later. Personal health history still matters.
• Safety screening comes first. Before BHRT, a provider should review cancer history, clotting history, cardiovascular risk, migraines, liver disease, abnormal bleeding, medications, family history, blood pressure, and screening status.
• The goal is not anti-aging. BHRT should be used to treat a clinically supported hormone-related pattern, not to chase high hormone levels, prevent normal aging, speed weight loss, or boost performance without a medical reason.

Understanding The Right Age To Start BHRT

BHRT stands for bioidentical hormone replacement therapy. It uses hormones that are chemically identical to hormones the body naturally makes, such as estradiol, progesterone, and testosterone.

People often ask about age because hormone changes are strongly tied to life stage. Women may notice symptoms in their 40s, sometimes earlier, as perimenopause begins. Men may notice low testosterone symptoms with age, weight changes, stress, poor sleep, illness, medications, or metabolic changes.

But age alone is not enough. A 42-year-old woman with severe night sweats, irregular cycles, anxiety, and poor sleep may need a hormone evaluation. Another 52-year-old woman with no symptoms may not need systemic hormone therapy at all. A 38-year-old woman with surgical menopause may need hormone therapy sooner. A 55-year-old man with fatigue but normal testosterone may need a sleep, thyroid, metabolic, or mental health evaluation instead of TRT.

The right question is not, “Am I old enough for BHRT?” The better question is, “Are my symptoms and health history consistent with a hormone-related change, and can hormone therapy be used safely for me?”

A responsible provider looks at age, symptoms, timing, labs when appropriate, medical history, and goals together.

When Women May Start BHRT During Perimenopause

Perimenopause is the transition leading up to menopause. It can begin years before periods stop. Many women begin noticing symptoms in their 40s, though some notice changes earlier.

During perimenopause, estrogen and progesterone can fluctuate unpredictably. Some months may feel normal, while others bring intense PMS, heavy or irregular periods, breast tenderness, migraines, anxiety, insomnia, hot flashes, night sweats, or mood swings.

BHRT may be considered during perimenopause when symptoms are significant and other causes have been reviewed. A woman does not always need to wait until her period has stopped completely to discuss hormone options.

However, perimenopause treatment should be individualized because cycles may still be occurring, pregnancy may still be possible, and hormone levels can fluctuate. Some women need cycle support, some need symptom-based hormone therapy, some need birth control, and some need non-hormonal options.

Before starting BHRT in perimenopause, a provider should evaluate bleeding patterns, pregnancy possibility, thyroid function, iron status, sleep, stress, medications, metabolic health, and whether abnormal bleeding needs further workup.

When Women May Start BHRT During Menopause

Menopause is usually defined as 12 months without a menstrual period, unless periods stopped because of surgery, medications, chemotherapy, or another medical cause.

Many women consider BHRT during the early menopause years when symptoms such as hot flashes, night sweats, poor sleep, mood changes, brain fog, joint aches, vaginal dryness, painful sex, urinary symptoms, or low libido are affecting quality of life.

For many patients, the most favorable time to discuss systemic menopause hormone therapy is closer to the menopause transition, especially when symptoms are bothersome and there are no major contraindications. This does not mean every woman should start BHRT at menopause, but it does mean timing is part of the risk-benefit discussion.

Some women need only local vaginal therapy rather than systemic therapy. Local vaginal estrogen or other local options may help vaginal dryness, painful sex, urinary urgency, and recurrent urinary discomfort without treating whole-body symptoms like hot flashes.

The decision should include symptom burden, age, time since menopause, uterus status, breast health, clotting risk, cardiovascular risk, family history, bone health, and personal preferences.

What About Early Menopause Or Surgical Menopause?

Some people need hormone therapy earlier than expected because menopause happens before the usual age range. This may occur because of premature ovarian insufficiency, surgical removal of the ovaries, chemotherapy, radiation, certain medications, autoimmune conditions, or genetic factors.

When estrogen drops early, the discussion is different from routine menopause at the usual age. Early estrogen loss can affect bones, vaginal and urinary tissues, sleep, mood, cardiovascular risk factors, sexual function, and quality of life.

Women with early menopause, premature ovarian insufficiency, or surgical menopause should discuss hormone therapy with a qualified provider unless there is a contraindication. The goal may include symptom relief and support for long-term health during years when the body would normally still be producing more estrogen.

Symptoms after surgical menopause can be sudden and intense because hormone levels drop quickly. Hot flashes, night sweats, insomnia, mood changes, vaginal dryness, low libido, and brain fog may appear rapidly.

These cases need individualized care, especially when surgery or treatment was related to cancer, endometriosis, genetic risk, or another complex condition.

At What Age Should Men Consider Testosterone Therapy?

Men should not start testosterone therapy based on age alone. Testosterone levels may decline gradually with age, but treatment is usually considered only when symptoms are present and testosterone levels are consistently low on proper morning testing.

Symptoms of testosterone deficiency may include low libido, fewer morning erections, erectile changes, fatigue, low motivation, depressed mood, reduced muscle, increased body fat, poor workout recovery, low bone density, or anemia in selected cases.

Testing should usually include morning total testosterone and often free testosterone, SHBG, LH, FSH, prolactin, CBC, CMP, lipids, A1C, glucose markers, and prostate-related screening when appropriate. Testosterone is often checked more than once because levels can vary.

Low testosterone can be caused or worsened by sleep apnea, insulin resistance, obesity, chronic illness, medications, alcohol, opioids, overtraining, under-eating, stress, depression, thyroid dysfunction, or pituitary and testicular conditions.

TRT may be appropriate at different ages when a true deficiency is present, but it should not be used as an anti-aging, bodybuilding, or performance-enhancement strategy.

Is It Ever Too Early To Start BHRT?

It may be too early to start BHRT when symptoms are mild, when hormone changes are not likely the main driver, or when safer first steps have not been addressed.

For example, fatigue in a 35-year-old may be caused by low iron, thyroid dysfunction, poor sleep, depression, insulin resistance, stress, gut problems, medication side effects, or sleep apnea. Starting hormones without evaluating these causes may miss the real problem.

Low libido may be related to painful sex, relationship stress, trauma history, medications, poor sleep, depression, low estrogen, low testosterone, thyroid dysfunction, or low ferritin. The right treatment depends on the cause.

Starting testosterone too early in men without proper diagnosis can suppress fertility, reduce natural testosterone signaling, and create long-term dependence on therapy that may not have been needed.

Starting estrogen or testosterone without safety screening can also create avoidable risk. Age is only one part of the decision.

Is It Ever Too Late To Start BHRT?

It is not always too late, but starting BHRT many years after menopause requires a more careful risk-benefit discussion.

For women, age and time since menopause can affect the risk profile of systemic hormone therapy. Starting closer to the menopause transition may have a different safety profile than starting much later. This is why a provider should review cardiovascular risk, clotting risk, breast health, liver health, migraines, blood pressure, and personal history before prescribing.

Some women who are not candidates for systemic hormone therapy may still be candidates for local vaginal therapy to treat dryness, painful sex, urinary urgency, or recurrent urinary discomfort.

For men, testosterone therapy later in life may still be considered when symptoms and labs support deficiency, but monitoring becomes especially important. Cardiovascular risk, prostate-related screening, sleep apnea, red blood cell count, medications, and overall health should be reviewed.

The decision should not be based only on age. It should be based on whether the expected benefit is meaningful and whether the safety profile is acceptable.

How It Works / What’s Involved

A BHRT evaluation starts with a detailed history. Your provider should ask about age, symptoms, menstrual pattern, menopause stage, hot flashes, night sweats, sleep, mood, libido, vaginal or urinary symptoms, weight changes, brain fog, medications, supplements, family history, cancer history, clotting history, migraines, and cardiovascular risk.

Testing may include estradiol, progesterone, FSH, LH, total and free testosterone, SHBG, DHEA-S, thyroid markers, thyroid antibodies, CBC, CMP, fasting glucose, fasting insulin, A1C, lipids, ferritin, iron studies, vitamin D, B12, and other labs based on symptoms and history.

For women, the plan may include estradiol, progesterone, testosterone in select cases, local vaginal estrogen, non-hormonal options, cycle support, sleep support, or metabolic care depending on symptoms and safety profile.

For men, the plan may include testosterone therapy only when symptoms and labs support deficiency. Fertility goals, sleep apnea risk, prostate monitoring, red blood cell count, cardiovascular risk, and medication history should be reviewed first.

Follow-up should include symptom tracking, side effect review, dose adjustment, lab monitoring when appropriate, blood pressure checks, medication review, bleeding pattern review in women, prostate-related monitoring in men, and updated age-appropriate screening.

Who It’s For And Who Should Be Cautious

BHRT may be appropriate for women in perimenopause or menopause with bothersome symptoms such as hot flashes, night sweats, poor sleep, mood changes, brain fog, vaginal dryness, painful sex, urinary symptoms, low libido, or quality-of-life changes.

It may be especially important to discuss hormone therapy earlier for women with premature ovarian insufficiency, early menopause, surgical menopause, or medically induced menopause, unless there is a contraindication.

Testosterone therapy may be appropriate for men with symptoms of testosterone deficiency and consistently low testosterone confirmed through proper testing.

People who should be cautious include those with unexplained bleeding, bleeding after menopause, cancer history, active or recent blood clots, clotting disorders, severe liver disease, uncontrolled blood pressure, high cardiovascular risk, migraines with aura, sleep apnea, fertility goals, prostate concerns, or complex medication histories.

BHRT should not be started for anti-aging, quick weight loss, athletic enhancement, or “optimization” without a clinically supported hormone-related reason.

Risks, Side Effects, and Monitoring

Possible estrogen side effects include breast tenderness, bloating, nausea, headaches, fluid retention, mood changes, skin irritation from patches or creams, or spotting. Abnormal bleeding, heavy bleeding, persistent bleeding, or bleeding after menopause should be evaluated.

Progesterone may cause sleepiness, dizziness, mood changes, bloating, breast tenderness, vivid dreams, or changes in bleeding patterns. If systemic estrogen is used and the uterus is present, progesterone or another appropriate progestogen is usually needed to protect the uterine lining.

Progesterone may also be appropriate for some women without a uterus when it supports sleep, mood, or hormone balance, but the reason is different than uterine protection and should be individualized. Progestins are synthetic progesterone-like medications, while micronized progesterone is bioidentical to the progesterone the body naturally makes.

Testosterone side effects may include acne, oily skin, unwanted hair growth, scalp hair thinning, irritability, sleep disruption, libido changes, or excessive levels. In men, testosterone therapy can also increase red blood cell count and suppress fertility.

Monitoring should include symptom response, side effects, blood pressure, bleeding pattern, breast health, pelvic health, cardiovascular risk factors, CBC, CMP, lipids, glucose and insulin markers, hormone levels when appropriate, prostate-related monitoring in men, and age-appropriate screening.

Safety

Seek urgent medical care right away for chest pain, severe shortness of breath, fainting, one-sided weakness or numbness, sudden severe headache, vision changes, severe leg swelling or calf pain, coughing blood, severe abdominal pain, suicidal thoughts, or confusion. These symptoms should not be treated as routine hormone side effects.

Call your provider for non-urgent but important concerns such as breast changes, persistent headaches, mood changes, acne, unwanted hair growth, scalp hair thinning, sleep disruption, abnormal bleeding, bleeding after menopause, pelvic pain, worsening hot flashes, urinary changes in men, fertility concerns, or symptoms that worsen after starting or changing hormone therapy.

Do not start estrogen, progesterone, testosterone, hormone pellets, thyroid products, fertility medications, high-dose supplements, or compounded hormone products based only on age or online advice. Safe hormone care depends on symptoms, medical history, testing, risk screening, dose, route, and follow-up monitoring.

Sources and Citations

• The 2025 Menopausal Hormone Therapy Guidelines — PMC
• The 2022 Hormone Therapy Position Statement — Menopause / PubMed
• Menopause — NCBI Bookshelf
• Hormone Replacement Therapy — NCBI Bookshelf
• Evidence-Based Guideline: Premature Ovarian Insufficiency — PMC
• Testosterone Deficiency Guideline — American Urological Association
• Testosterone Therapy in Men With Hypogonadism — Endocrine Society